Skip to main content
RAPID MICRO BIOSYSTEMS, INC. logo

RAPID MICRO BIOSYSTEMS, INC. — Investor Relations & Filings

Ticker · RPID ISIN · US75340L1044 US Manufacturing
Filings indexed 288 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country US United States of America
Listing US RPID

About RAPID MICRO BIOSYSTEMS, INC.

https://www.rapidmicrobio.com/

Rapid Micro Biosystems, Inc. is a life sciences technology company that provides automation solutions for quality control (QC) microbiology. The company's flagship product, the Growth Direct® System, automates rapid microbial detection for pharmaceutical and biomanufacturing companies. This technology is applied to critical testing areas, including environmental monitoring, water testing, bioburden analysis, and sterility testing. The system is designed to replace traditional, manual methods, thereby increasing operational efficiency, improving data integrity and regulatory compliance, and reducing the potential for human error. By providing faster results, the Growth Direct® System helps manufacturers minimize the impact of contamination events, reduce investigation times, and accelerate product release.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings
2026-05-29 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a Form 8-K filing (Current Report) containing Item 5.07 – Submission of Matters to a Vote of Security Holders. It provides detailed vote counts for the election of a director and the ratification of the auditor at the company’s Annual Meeting. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements" (DVA), which covers official results from shareholder votes at any general meeting.
2026-05-28 English
FORM 8-K
Capital/Financing Update Classification · 90% confidence The document is a U.S. SEC Form 8-K “Current Report” disclosing Item 1.01: entry into material definitive agreements for an underwritten offering of common stock and warrants and a concurrent registered direct offering. These are direct capital raising and financing transactions. Under our taxonomy, this falls squarely under “Capital/Financing Update” (CAP).
2026-05-19 English
424B5
Regulatory Filings Classification · 89% confidence The document is a Form 424B5 prospectus supplement (filed pursuant to Rule 424(b)(5)) to a shelf registration statement, outlining an equity offering of Class A common stock and warrants. It is a regulatory compliance filing for a securities offering and does not contain financial statements, earnings highlights, management discussion, or other report content. It does not fit categories like Annual Report, Interim Report, Earnings Release, proxy materials, or M&A filings. This is a general SEC regulatory announcement/filing and is best classified as Regulatory Filings (RNS).
2026-05-19 English
424B5
Regulatory Filings
2026-05-19 English
10-Q
Interim / Quarterly Report Q1 2026
2026-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.